superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2017-06-30
- Valid until
- 2017-09-30
- Published
- 2017-08-03
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 529,749,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Regeneron Pharmaceuticals quarterly research and development: 509,975,000 United States dollar", as of 2017-06-30 (until 2017-09-30). Claim clm_F6A5C3C217BB, https://asof.is/claim/clm_F6A5C3C217BB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217617000027/0001532176-17-000027-index.htm.
APA
AsOf. (2017). Regeneron Pharmaceuticals quarterly research and development: 509,975,000 United States dollar (as of 2017-06-30 (until 2017-09-30)) [Record clm_F6A5C3C217BB]. Retrieved November 9, 2026, from https://asof.is/claim/clm_F6A5C3C217BB (source: https://www.sec.gov/Archives/edgar/data/872589/000153217617000027/0001532176-17-000027-index.htm)
BibTeX
@misc{asof_clm_F6A5C3C217BB,
author = {AsOf},
title = {Regeneron Pharmaceuticals quarterly research and development: 509,975,000 United States dollar},
year = {2017},
howpublished = {\url{https://asof.is/claim/clm_F6A5C3C217BB}},
note = {Claim clm\_F6A5C3C217BB, as of 2017-06-30 (until 2017-09-30); source: https://www.sec.gov/Archives/edgar/data/872589/000153217617000027/0001532176-17-000027-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_F6A5C3C217BB.md/v1/claims/clm_F6A5C3C217BBsubmit a correction